However, we recognize that other factors, such as tumor location, grade, IDH1 mutation, edema, and the use of anti-epileptic drugs30,85,86 may influence cognitive outcomes and we therefore suggest that larger sample studies should further explore such a more comprehensive model. The gene discussed is IDH1; the disease is neoplasm.